Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.

In a nutshell Researchers discovered how a specific genetic mutation (PIK3CA) changes the way blood vessel cancers grow and ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Three very important feasts and the pattern of the Tabernacle and the Ark of the Covenant — all symbolic of Christ and His relationship with believers today. And let them make Me a Sanctuary; that I ...